STOCK TITAN

Aemetis Reports Second Quarter 2025 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Aemetis (NASDAQ: AMTX) reported Q2 2025 financial results, with revenues increasing to $52.2 million, up $9.3 million from Q1 2025. The growth was driven by California Ethanol, Dairy Renewable Natural Gas operations, and renewed India biodiesel deliveries.

Key highlights include $3.1 million in revenue from 11 dairy digesters, CARB approval for 7 new LCFS pathways, and a $27 million agreement with NPL for H₂S and compression units. The company's operating loss improved by $4.9 million from Q1 2025, while net loss was $23.4 million, better than $29.2 million in Q2 2024.

The India subsidiary appointed a new CFO with IPO experience, targeting a public listing in early 2026. The company expects increased tax credit income and operating cash flow from its California Ethanol segment through a mechanical vapor recompression project.

Aemetis (NASDAQ: AMTX) ha riportato i risultati finanziari del secondo trimestre 2025, con ricavi in aumento a 52,2 milioni di dollari, in crescita di 9,3 milioni di dollari rispetto al primo trimestre 2025. La crescita è stata trainata dalle attività di etanolo in California, dal gas naturale rinnovabile da allevamenti lattiero-caseari e dalle consegne rinnovate di biodiesel in India.

I punti salienti includono 3,1 milioni di dollari di ricavi derivanti da 11 digestori per allevamenti lattiero-caseari, l'approvazione da parte di CARB di 7 nuovi percorsi LCFS e un accordo da 27 milioni di dollari con NPL per unità di H₂S e compressione. La perdita operativa dell'azienda è migliorata di 4,9 milioni di dollari rispetto al primo trimestre 2025, mentre la perdita netta è stata di 23,4 milioni di dollari, migliore rispetto ai 29,2 milioni del secondo trimestre 2024.

La controllata in India ha nominato un nuovo CFO con esperienza in IPO, puntando a una quotazione pubblica all'inizio del 2026. L'azienda prevede un aumento dei crediti d'imposta e del flusso di cassa operativo dal segmento Etanolo California grazie a un progetto di ricompressione meccanica del vapore.

Aemetis (NASDAQ: AMTX) informó los resultados financieros del segundo trimestre de 2025, con ingresos que aumentaron a 52,2 millones de dólares, un incremento de 9,3 millones respecto al primer trimestre de 2025. El crecimiento fue impulsado por las operaciones de etanol en California, gas natural renovable de lácteos y las renovadas entregas de biodiésel en India.

Los aspectos destacados incluyen 3,1 millones de dólares en ingresos provenientes de 11 digestores lácteos, la aprobación de CARB para 7 nuevas vías LCFS y un acuerdo de 27 millones de dólares con NPL para unidades de H₂S y compresión. La pérdida operativa mejoró en 4,9 millones desde el primer trimestre de 2025, mientras que la pérdida neta fue de 23,4 millones de dólares, mejor que los 29,2 millones del segundo trimestre de 2024.

La filial en India nombró un nuevo CFO con experiencia en IPO, con la meta de una oferta pública a principios de 2026. La compañía espera un aumento en los créditos fiscales y en el flujo de caja operativo de su segmento de Etanol en California gracias a un proyecto de recomprensión mecánica de vapor.

Aemetis (NASDAQ: AMTX)는 2025년 2분기 재무 실적을 발표했으며, 매출은 1분기 2025년 대비 930만 달러 증가한 5,220만 달러를 기록했습니다. 성장은 캘리포니아 에탄올, 낙농업 재생 천연가스 운영 및 인도 바이오디젤 납품 재개에 힘입은 것입니다.

주요 내용으로는 11개 낙농소화조에서 310만 달러의 수익, CARB의 7개 신규 LCFS 경로 승인, H₂S 및 압축 장치를 위한 2,700만 달러 규모의 NPL과의 계약이 포함됩니다. 회사의 영업손실은 2025년 1분기 대비 490만 달러 개선되었으며, 순손실은 2,340만 달러로 2024년 2분기 2,920만 달러보다 나아졌습니다.

인도 자회사는 IPO 경험이 있는 새로운 CFO를 임명했으며, 2026년 초 공개 상장을 목표로 하고 있습니다. 회사는 기계식 증기 재압축 프로젝트를 통해 캘리포니아 에탄올 부문에서 세금 공제 수입과 영업 현금 흐름 증가를 기대하고 있습니다.

Aemetis (NASDAQ : AMTX) a publié ses résultats financiers du deuxième trimestre 2025, avec un chiffre d'affaires en hausse à 52,2 millions de dollars, soit une augmentation de 9,3 millions par rapport au premier trimestre 2025. Cette croissance a été portée par les opérations d'éthanol en Californie, le gaz naturel renouvelable issu des exploitations laitières et la reprise des livraisons de biodiesel en Inde.

Les points clés incluent 3,1 millions de dollars de revenus provenant de 11 digesteurs laitiers, l'approbation par le CARB de 7 nouvelles voies LCFS, et un contrat de 27 millions de dollars avec NPL pour des unités de H₂S et de compression. La perte d'exploitation de la société s'est améliorée de 4,9 millions par rapport au premier trimestre 2025, tandis que la perte nette s'établit à 23,4 millions de dollars, meilleure que les 29,2 millions du deuxième trimestre 2024.

La filiale en Inde a nommé un nouveau directeur financier expérimenté en introduction en bourse, visant une cotation publique début 2026. La société prévoit une augmentation des crédits d'impôt et des flux de trésorerie opérationnels de son segment Éthanol Californie grâce à un projet de recompression mécanique de vapeur.

Aemetis (NASDAQ: AMTX) meldete die Finanzergebnisse für das zweite Quartal 2025 mit einem Umsatzanstieg auf 52,2 Millionen US-Dollar, eine Steigerung von 9,3 Millionen gegenüber dem ersten Quartal 2025. Das Wachstum wurde durch die Ethanolproduktion in Kalifornien, erneuerbares Biomethan aus Milchviehbetrieben und erneute Biodiesellieferungen in Indien angetrieben.

Zu den wichtigsten Highlights zählen 3,1 Millionen US-Dollar Umsatz aus 11 Milchvieh-Digesteranlagen, die CARB-Zulassung für 7 neue LCFS-Pfade und eine 27-Millionen-Dollar-Vereinbarung mit NPL für H₂S- und Kompressionseinheiten. Der operative Verlust des Unternehmens verbesserte sich um 4,9 Millionen gegenüber dem ersten Quartal 2025, während der Nettoverlust bei 23,4 Millionen US-Dollar lag und damit besser war als die 29,2 Millionen im zweiten Quartal 2024.

Die indische Tochtergesellschaft ernannte einen neuen CFO mit IPO-Erfahrung und strebt eine Börsennotierung Anfang 2026 an. Das Unternehmen erwartet durch ein mechanisches Dampfrekompressionsprojekt im Segment Kalifornisches Ethanol höhere Steuergutschriften und operativen Cashflow.

Positive
  • Revenue increased by $9.3M quarter-over-quarter to $52.2M
  • Operating loss improved by $4.9M from Q1 2025
  • Net loss improved to $23.4M from $29.2M year-over-year
  • SG&A expenses decreased significantly to $7.3M from $11.8M year-over-year
  • Biogas segment generated $3.1M revenue from 11 operating dairy digesters
  • Secured $27M agreement with NPL for dairy digester infrastructure
  • India subsidiary preparing for potential IPO in early 2026
Negative
  • Gross loss of $3.4M compared to $1.8M loss in Q2 2024
  • Total revenue declined year-over-year from $66.6M to $52.2M
  • Interest expense increased to $12.3M from $11.7M year-over-year
  • Low cash position of $1.6M at quarter end
  • Six-month revenue declined to $95.1M from $139.2M year-over-year

Insights

Aemetis shows revenue growth but continues to operate at a loss despite improvements in biogas segment and reduced expenses.

Aemetis reported $52.2 million in Q2 2025 revenue, a $9.3 million increase from Q1, primarily driven by the restart of India biodiesel deliveries and continued growth in their biogas segment. However, despite the revenue growth, the company posted a gross loss of $3.4 million and an operating loss of $10.7 million.

The company's Dairy Renewable Natural Gas segment is showing promise, with $3.1 million in revenue from 11 operating digesters that produced 106,400 MMBtu. This segment received a boost with CARB's approval of 7 new LCFS pathways, which should enhance future revenue potential. Additionally, the $27 million agreement with NPL to construct H₂S and compression units for 15 dairy digesters signals continued expansion of this business line.

On the positive side, SG&A expenses decreased significantly to $7.3 million from $11.8 million in Q2 2024, contributing to the $2.9 million improvement in operating loss year-over-year. The net loss of $23.4 million shows improvement from $29.2 million in the same period last year.

The cash position remains concerning at just $1.6 million, though this represents an improvement from $900,000 at the end of 2024. The company's high interest expense of $12.3 million for the quarter continues to be a substantial drag on profitability, representing nearly 24% of quarterly revenue going toward interest payments.

The planned IPO of the India subsidiary in early 2026 could potentially provide a significant capital infusion, and management expects future revenue enhancement from federal Section 45Z production tax credits. The mechanical vapor recompression project, once completed, should reduce natural gas consumption and improve operating cash flow in their California Ethanol segment.

  • Revenue increased $9.3M from the first quarter of 2025 to $52.2M, driven by the restart of India biodiesel deliveries under new order from Oil Marketing Companies.
  • Aemetis Biogas recognized $3.1M in revenue from 11 digesters; CARB approved 7 new LCFS pathways in Q2.
  • Signed $27M agreement with NPL to construct H₂S and compression units for 15 dairy digesters.
  • Operating loss improved by $4.9M from the first quarter of 2025, reflecting reduced SG&A in the second quarter of 2025; net loss flat from the second quarter of 2024 after adjusting for one-time items.
  • Appointed new CFO with IPO experience for our India subsidiary. The India subsidiary is targeting a public listing in early 2026.

CUPERTINO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on low and negative carbon intensity products that lower fuel costs and reduce emissions, today announced its financial results for the three and six months ended June 30, 2025.

“Revenues of $52.2 million during the second quarter of 2025 are an increase of $9.3 million from the $42.9 million revenues during the first quarter of 2025, reflecting continued execution by our California Ethanol and Dairy Renewable Natural Gas segments, along with the fulfillment of new India Oil Marketing Companies orders,” said Todd Waltz, Chief Financial Officer of Aemetis. “We look forward to additional revenues from the seven dairy digester RNG pathways recently approved by CARB and the revenues from federal Section 45Z production tax credits that were extended to year 2029 in the One Big Beautiful Bill Act,” added Waltz.

“We are pleased with the continued growth of Aemetis Biogas production and continued progress with building a large dairy digester to process waste from multiple dairies which is already producing biogas and will be completed in August,” said Eric McAfee, Chairman and CEO of Aemetis. “The Section 45Z tax credit income and operating cash flow is expected to be significantly increased in our California Ethanol segment by reducing natural gas consumption with the mechanical vapor recompression project that has completed several steps of fabrication and construction.”

Today, Aemetis will host an earnings review call at 11:00 a.m. Pacific time (PT).

Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 655740
Live Participant Dial In (International): +1-973-528-0011 entry code 655740
Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/52764

For details on the call, please visit http://www.aemetis.com/investors/conference-calls/

Financial Results for the Three Months Ended June 30, 2025

Total revenues during the second quarter of 2025 were $52.2 million compared to $66.6 million for the second quarter of 2024. Our Keyes plant operated at a slightly lower grind rate to maximize margins during the second quarter of 2025. Our Dairy Natural Gas segment produced 106,400 MMBtu from eleven operating dairy digesters and reported $3.1 million of revenue. Our India Biodiesel business recognized $11.9 million of revenue primarily from the new allocation that converted into sales to the India Oil Marketing Companies during the second quarter of 2025.

Gross loss for the second quarter of 2025 was $3.4 million compared to a $1.8 million gross loss during the second quarter of 2024.

Selling, general and administrative expenses were $7.3 million during the second quarter of 2025 which was a significant decrease from $11.8 million during the same period in 2024, driven primarily by the recognition of a loss on asset disposals of $3.6 million during the second quarter of 2024.

Operating loss was $10.7 million for the second quarter of 2025, an improvement from the operating loss of $13.6 million for the same period in 2024.

Interest expense, excluding accretion of Series A preferred units in the Aemetis Biogas LLC subsidiary, increased slightly to $12.3 million during the second quarter of 2025 compared to $11.7 million during the second quarter of 2024. Additionally, Aemetis Biogas recognized $2.0 million of accretion of Series A preferred units during the second quarter of 2025, a large decrease from $3.5 million during the second quarter of 2024.

Net loss was $23.4 million for the second quarter of 2025, a significant improvement from $29.2 million for the second quarter of 2024.

Cash at the end of the second quarter of 2025 was $1.6 million compared to $900 thousand at the close of 2024. We recorded investments in capital projects related to the reduction of the carbon intensity of Aemetis ethanol and construction of dairy digesters of $3.6 million for the second quarter of 2025.

Financial Results for the Six Months Ended June 30, 2025

Revenues were $95.1 million for the first half of 2025 compared to $139.2 million for the first half of 2024, with the lower amount primarily due to delays with the receipt of contracts in India from the government-owned Oil Marketing Companies.

Gross loss for the first half of 2025 was $8.4 million compared to a gross loss of $2.4 million during the first half of 2024.

Selling, general and administrative expenses were $17.8 million during the first half of 2025 compared to $20.7 million during the first half of 2024, including the recognition of a loss on asset disposals of $3.6 million during the first half of 2024.

Operating loss was $26.2 million for the first half of 2025 compared to $23.1 million for the first half of 2024.

Interest expense was $26.0 million during the first half of 2025, excluding accretion and other expenses of Series A preferred units in our Aemetis Biogas LLC subsidiary, compared to interest expense of $22.2 million during the first half of 2024. Additionally, our Aemetis Biogas LLC subsidiary recognized $4.3 million of accretion and other expenses in connection with preference payments on its preferred units during the first half of 2025 compared to $6.8 million during the first half of 2024.

Net loss for the first half of 2025 was $47.9 million, an improvement from a net loss of $53.4 million during the same period of 2024.

Investments in capital projects of $5.4 million were made during the first half of 2025, including investments in capital projects related to Aemetis Biogas of $4.1 million.

About Aemetis

Headquartered in Cupertino, California, Aemetis is a renewable natural gas, renewable fuel, and biochemicals company focused on the operation, acquisition, development, and commercialization of innovative technologies that lower fuel costs and reduce emissions. Founded in 2006, Aemetis is operating and actively expanding a California biogas digester network and pipeline system to convert dairy waste gas into Renewable Natural Gas. Aemetis owns and operates a 65 million gallon per year ethanol production facility in California’s Central Valley near Modesto that supplies about 80 dairies with animal feed. Aemetis owns and operates an 80 million gallon per year production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis is developing a sustainable aviation fuel (SAF) and renewable diesel fuel biorefinery in California to utilize renewable hydrogen, hydroelectric power, and renewable oils to produce low carbon intensity renewable jet and diesel fuel. For additional information about Aemetis, please visit www.aemetis.com

Company Investor Relations

Media Contact:
Todd Waltz
(408) 213-0940
investors@aemetis.com

External Investor Relations

Contact:
Kirin Smith
PCG Advisory Group
(646) 863-6519
ksmith@pcgadvisory.com

Non-GAAP Financial Information

We have provided non-GAAP measures as a supplement to financial results based on GAAP. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is included in the accompanying supplemental data. Adjusted EBITDA is defined as net income/(loss) plus (to the extent deducted in calculating such net income) interest and amortization expense, income tax expense or benefit, accretion expense, depreciation expense, and share-based compensation expense.

Adjusted EBITDA is not calculated in accordance with GAAP and should not be considered as an alternative to net income/(loss), operating income or any other performance measures derived in accordance with GAAP or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA is presented solely as a supplemental disclosure because management believes that it is a useful performance measure that is widely used within the industry in which we operate. In addition, management uses Adjusted EBITDA for reviewing financial results and for budgeting and planning purposes. EBITDA measures are not calculated in the same manner by all companies and, accordingly, may not be an appropriate measure for comparison.

Safe Harbor Statement

This news release contains forward-looking statements, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements in this news release include, without limitation, statements relating to our five-year growth plan; trends in market conditions with respect to prices for inputs for our products versus prices for our products; our ability to fund, develop, build, maintain and operate digesters, facilities and pipelines for our dairy renewable natural gas segment; our ability to fund, develop and operate our SAF, renewable diesel, and carbon capture and sequestration projects, including obtaining required permits; our ability to receive awarded grants by meeting all of the required conditions, including meeting the minimum contributions; our intention to repurchase the Series A preferred units relating to our Aemetis Biogas subsidiary and the expected valuation premium thereof; and our ability to raise additional capital. Words or phrases such as “anticipates,” “may,” “will,” “should,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “showing signs,” “targets,” “will likely result,” “will continue” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol, biodiesel and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, customer adoption, counter-party risks, risks associated with changes to federal policy or regulation, and other risks detailed in our reports filed with the Securities and Exchange Commission, including our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and other filed documents. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.

(Tables follow)


AEMETIS, INC.
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(unaudited, in thousands, except per share data)
           
    For the three months ended
June 30,
 For the six months ended
June 30,
     2025   2024   2025   2024 
           
Revenues $52,243  $66,561  $95,129  $139,195 
Cost of goods sold  55,598   68,367   103,564   141,613 
Gross loss  (3,355)  (1,806)  (8,435)  (2,418)
           
Selling, general and administrative expenses  7,319   11,800   17,794   20,650 
Operating loss  (10,674)  (13,606)  (26,229)  (23,068)
           
Other expense (income):        
 Interest expense        
  Interest rate expense  11,235   9,904   22,253   18,996 
  Debt related fees and amortization expense 1,095   1,820   3,770   3,241 
  Accretion and other expenses of Series A preferred units 2,032   3,477   4,311   6,788 
 Other (income) expense  (1,112)  (18)  (1,327)  49 
Loss before income taxes  (23,924)  (28,789)  (55,236)  (52,142)
 Income tax expense (benefit)  (529)  385   (7,312)  1,263 
Net loss $(23,395) $(29,174) $(47,924) $(53,405)
           
Net loss per common share        
 Basic $(0.41) $(0.66) $(0.87) $(1.24)
 Diluted $(0.41) $(0.66) $(0.87) $(1.24)
           
Weighted average shares outstanding        
 Basic  57,676   44,417   55,144   43,153 
 Diluted  57,676   44,417   55,144   43,153 
           


AEMETIS, INC.
CONSOLIDATED CONDENSED BALANCE SHEETS
(in thousands)
      
   June 30, 2025 December 31, 2024
   (Unaudited)  
Assets    
 Current assets:   
  Cash and cash equivalents$1,645  $898 
  Accounts receivable 2,699   1,805 
  Inventories 12,371   25,442 
  Tax credit sale receivable -   12,300 
  Prepaid and other current assets 3,371   4,251 
 Total current assets 20,086   44,696 
      
  Property, plant and equipment, net 204,641   199,392 
  Other assets 15,289   15,214 
 Total assets$240,016  $259,302 
      
Liabilities and stockholders' deficit   
 Current liabilities:   
  Accounts payable$21,894  $33,139 
  Current portion of long term debt 247,615   63,745 
  Short term borrowings 22,995   26,789 
  Other current liabilities 29,423   20,295 
 Total current liabilities 321,927   143,968 
      
 Total long term liabilities 207,344   379,262 
      
 Stockholders' deficit:   
  Common stock 62   51 
  Additional paid-in capital 327,905   305,329 
  Accumulated deficit (610,866)  (562,942)
  Accumulated other comprehensive loss (6,356)  (6,366)
 Total stockholders' deficit (289,255)  (263,928)
Total liabilities and stockholders' deficit$240,016  $259,302 
     


AEMETIS, INC.
RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME/(LOSS)
(unaudited, in thousands)
         
         
  For the three months ended June 30, For the six months ended June 30,
EBITDA Calculation 2025   2024   2025   2024 
         
Net income (loss)$(23,395) $(29,174) $(47,924) $(53,405)
Adjustments       
 Interest and amortization expense 12,341   11,736   26,046   22,261 
 Depreciation expense 2,350   2,049   4,708   3,847 
 Accretion of Series A preferred units 2,032   3,477   4,311   6,788 
 Loss on asset disposal -   3,644   -   3,644 
 Share-based compensation 1,433   1,977   3,741   4,946 
 Income tax expense (benefit) (529)  385   (7,312)  1,263 
Total adjustments 17,627   23,268   31,494   42,749 
         
Adjusted EBITDA$(5,768) $(5,906) $(16,430) $(10,656)
         


AEMETIS, INC.
PRODUCTION AND PRICE PERFORMANCE
(unaudited)
          
 Three Months ended June 30, Six Months ended June 30,
  2025  2024   2025  2024 
          
California Ethanol         
Ethanol         
Gallons sold (in millions) 13.8  14.8   27.9  28.9 
Average sales price/gallon$2.01 $1.99  $2.00 $1.89 
Percent of nameplate capacity 100% 108%  102% 105%
WDG         
Tons sold (in thousands) 91.0  105.0   184.1  199.0 
Average sales price/ton$86 $89  $86 $93 
Delivered Cost of Corn         
Bushels ground (in millions) 4.7  5.2   9.4  10.1 
Average delivered cost / bushel$6.42 $6.36  $6.53 $6.35 
          
California Dairy Renewable Natural Gas         
Renewable Natural Gas          
MMBtu sold (in thousands) 106.4  88.0   177.3  148.8 
Average price per MMBtu$2.75 $2.19  $3.11 $2.94 
RINs          
RINs sold (in thousands) 763.6  341.0   1,151.8  1,107.3 
Average price per RIN$2.60 $3.17  $2.61 $3.11 
LCFS         
LCFS credits sold (in thousands) 14.0  5.0   30.0  23.0 
Average price per LCFS credit$55.25 $64.75  $64.45 $65.73 
          
India Biodiesel         
Biodiesel         
Metric tons sold (in thousands) 9.4  20.4   9.4  47.5 
Average Sales Price/Metric ton$1,010 $1,162  $1,010 $1,150 
Percent of Nameplate Capacity 25.2% 54.4%  12.6% 63.4%
Refined Glycerin         
Metric tons sold (in thousands) 0.1  1.5   0.1  3.9 
Average Sales Price/Metric ton$879 $635  $879 $584 
          


FAQ

What were Aemetis (AMTX) Q2 2025 earnings results?

Aemetis reported Q2 2025 revenue of $52.2 million, a net loss of $23.4 million, and a gross loss of $3.4 million. Revenue increased by $9.3 million from Q1 2025 but decreased from $66.6 million in Q2 2024.

How much revenue did Aemetis generate from its biogas operations in Q2 2025?

Aemetis Biogas generated $3.1 million in revenue from eleven operating dairy digesters, producing 106,400 MMBtu during Q2 2025.

What is Aemetis's cash position as of Q2 2025?

Aemetis reported a cash position of $1.6 million at the end of Q2 2025, up from $900,000 at the end of 2024.

When is Aemetis planning to IPO its India subsidiary?

Aemetis's India subsidiary is targeting a public listing in early 2026 and has appointed a new CFO with IPO experience to prepare for this initiative.

How many new LCFS pathways did CARB approve for Aemetis in Q2 2025?

CARB (California Air Resources Board) approved 7 new LCFS (Low Carbon Fuel Standard) pathways for Aemetis during Q2 2025.
Aemetis

NASDAQ:AMTX

AMTX Rankings

AMTX Latest News

AMTX Latest SEC Filings

AMTX Stock Data

148.39M
50.70M
8.42%
21.01%
8.27%
Specialty Chemicals
Industrial Organic Chemicals
Link
United States
CUPERTINO